共 50 条
- [41] Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson’s disease Journal of Neurology, 2016, 263 : 250 - 256
- [43] Comparison of pharmacokinetics and pharmacodynamics of combined immediate- and extended-release (IR+ER)/carbidopa/levodopa formulations (VADOVA IR+ER) with IR carbidopa/levodopa and controlled-release (CR) carbidopa/levodopa in Parkinson's disease (PD) MOVEMENT DISORDERS, 2007, 22 : S223 - S223
- [46] Application of Pharmacokinetics and Pharmacodynamics in Product Life Cycle Management. A Case Study with a Carbidopa-Levodopa Extended-Release Formulation AAPS JOURNAL, 2017, 19 (03): : 607 - 618
- [47] Application of Pharmacokinetics and Pharmacodynamics in Product Life Cycle Management. A Case Study with a Carbidopa-Levodopa Extended-Release Formulation The AAPS Journal, 2017, 19 : 607 - 618